HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia
C Weber,
W Erl,
KS Weber,
and
PC Weber
Institut fur Prophylaxe der Kreislaufkrankheiten, Ludwig-Maximilians-Universitat, Munich, Germany.
OBJECTIVES: This study sought to determine whether inhibitors of 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase affect CD11b expression and adhesiveness of monocytes in vitro and after treatment of patients with hypercholesterolemia. BACKGROUND: HMG-CoA reductase inhibitors improve survival of patients with coronary heart disease (CHD) and prevent CHD in hypercholesterolemic men. Because these drugs have been shown to modulate monocyte functions, they may act by reducing monocyte adhesion to endothelium, which is crucial in atherogenesis. METHODS: Isolated human blood monocytes were subjected to flow cytometric detection of CD11b and adhesion assays on fixed human endothelial cells after treatment with lovastatin in vitro or ex vivo before and after treatment of hypercholesterolemic patients with HMG-CoA reductase inhibitors. RESULTS: The integrin heterodimer CD11b/CD18 expressed on monocytes interacts with intercellular adhesion molecule-1 on endothelium and is involved in monocyte adhesion to endothelium. Treatment of monocytes with lovastatin in vitro slightly and dose dependently reduced surface expression of CD11b on monocytes. Moreover, lovastatin inhibited CD11b-dependent adhesiveness to fixed endothelium of unstimulated monocytes or monocytes stimulated with monocyte chemotactic protein 1. Coincubation with mevalonate, but not with low density lipoprotein (LDL), reversed the effects of lovastatin, suggesting that early cholesterol precursors, but not cholesterol, are crucial for adhesiveness of CD11b. In hypercholesterolemic patients, adhesion of isolated monocytes to endothelium ex vivo was dramatically increased over values in healthy control subjects. Treatment of these patients with the HMG-CoA reductase inhibitors lovastatin or simvastatin (20 to 40 mg/day) for 6 weeks slightly decreased total and LDL cholesterol plasma levels and monocyte CD11b surface expression but resulted in a significant reduction of monocyte adhesion to endothelium (p < 0.01, n = 7). CONCLUSIONS: The reduction of CD11b expression and inhibition of CD11b-dependent monocyte adhesion to endothelium may crucially contribute to the clinical benefit of HMG-CoA reductase inhibitors in CHD, independent of cholesterol-lowering effects.
This article has been cited by other articles:
|
|
|
|
 
V. Chopra and S. A. Flanders
Does Statin Use Improve Pneumonia Outcomes?
Chest,
November 1, 2009;
136(5):
1381 - 1388.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Patel, B. G. Drew, S. Nakhla, S. J. Duffy, A. J. Murphy, P. J. Barter, K.-A. Rye, J. Chin-Dusting, A. Hoang, D. Sviridov, et al.
Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.
J. Am. Coll. Cardiol.,
March 17, 2009;
53(11):
962 - 971.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. M. Maher, T. N. Dhonnchu, J. P. Burke, A. Soo, A. E. Wood, and R. W. G. Watson
Statins alter neutrophil migration by modulating cellular Rho activity--a potential mechanism for statins-mediated pleotropic effects?
J. Leukoc. Biol.,
January 1, 2009;
85(1):
186 - 193.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Alipour, A. J.H. H.M van Oostrom, A. Izraeljan, C. Verseyden, J. M. Collins, K. N. Frayn, T. W.M. Plokker, J. W. F. Elte, and M. Castro Cabezas
Leukocyte Activation by Triglyceride-Rich Lipoproteins
Arterioscler Thromb Vasc Biol,
April 1, 2008;
28(4):
792 - 797.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Gao, L. Linhartova, A. McD. Johnston, and D. R. Thickett
Statins and sepsis
Br. J. Anaesth.,
March 1, 2008;
100(3):
288 - 298.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Ferdinandy, R. Schulz, and G. F. Baxter
Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning
Pharmacol. Rev.,
December 1, 2007;
59(4):
418 - 458.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Yamada, E. Sakurai, M. Itaya, S. Yamasaki, and Y. Ogura
Inhibition of Laser-Induced Choroidal Neovascularization by Atorvastatin by Downregulation of Monocyte Chemotactic Protein-1 Synthesis in Mice
Invest. Ophthalmol. Vis. Sci.,
April 1, 2007;
48(4):
1839 - 1843.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Patti, M. Chello, V. Pasceri, D. Colonna, A. Nusca, M. Miglionico, A. D'Ambrosio, E. Covino, and G. Di Sciascio
Protection From Procedural Myocardial Injury by Atorvastatin Is Associated With Lower Levels of Adhesion Molecules After Percutaneous Coronary Intervention: Results From the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) Substudy
J. Am. Coll. Cardiol.,
October 17, 2006;
48(8):
1560 - 1566.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Chandrasekar, S. Mummidi, L. Mahimainathan, D. N. Patel, S. R. Bailey, S. Z. Imam, W. C. Greene, and A. J. Valente
Interleukin-18-induced Human Coronary Artery Smooth Muscle Cell Migration Is Dependent on NF-{kappa}B- and AP-1-mediated Matrix Metalloproteinase-9 Expression and Is Inhibited by Atorvastatin
J. Biol. Chem.,
June 2, 2006;
281(22):
15099 - 15109.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. J. Zambarakji, T. Nakazawa, E. Connolly, A. M. Lane, S. Mallemadugula, M. Kaplan, N. Michaud, A. Hafezi-Moghadam, E. S. Gragoudas, and J. W. Miller
Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization.
Invest. Ophthalmol. Vis. Sci.,
June 1, 2006;
47(6):
2623 - 2631.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Kawakami, M. Aikawa, P. Libby, P. Alcaide, F. W. Luscinskas, and F. M. Sacks
Apolipoprotein CIII in Apolipoprotein B Lipoproteins Enhances the Adhesion of Human Monocytic Cells to Endothelial Cells
Circulation,
February 7, 2006;
113(5):
691 - 700.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Quehenberger
Thematic Review Series: The Immune System and Atherogenesis. Molecular mechanisms regulating monocyte recruitment in atherosclerosis
J. Lipid Res.,
August 1, 2005;
46(8):
1582 - 1590.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. W. Merx, E. A. Liehn, J. Graf, A. van de Sandt, M. Schaltenbrand, J. Schrader, P. Hanrath, and C. Weber
Statin Treatment After Onset of Sepsis in a Murine Model Improves Survival
Circulation,
July 5, 2005;
112(1):
117 - 124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. L. Francone, L. Royer, G. Boucher, M. Haghpassand, A. Freeman, D. Brees, and R. J. Aiello
Increased Cholesterol Deposition, Expression of Scavenger Receptors, and Response to Chemotactic Factors in Abca1-Deficient Macrophages
Arterioscler Thromb Vasc Biol,
June 1, 2005;
25(6):
1198 - 1205.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Pleiner, G. Schaller, F. Mittermayer, S. Zorn, C. Marsik, S. Polterauer, S. Kapiotis, and M. Wolzt
Simvastatin Prevents Vascular Hyporeactivity During Inflammation
Circulation,
November 23, 2004;
110(21):
3349 - 3354.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. W. Merx, E. A. Liehn, U. Janssens, R. Lutticken, J. Schrader, P. Hanrath, and C. Weber
HMG-CoA Reductase Inhibitor Simvastatin Profoundly Improves Survival in a Murine Model of Sepsis
Circulation,
June 1, 2004;
109(21):
2560 - 2565.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Schonbeck and P. Libby
Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents?
Circulation,
June 1, 2004;
109(21_suppl_1):
II-18 - II-26.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Han, X. Zhou, T. Yokoyama, D. P. Hajjar, A. M. Gotto Jr, and A. C. Nicholson
Pitavastatin Downregulates Expression of the Macrophage Type B Scavenger Receptor, CD36
Circulation,
February 17, 2004;
109(6):
790 - 796.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Monick, L. S. Powers, N. S. Butler, and G. W. Hunninghake
Inhibition of Rho Family GTPases Results in Increased TNF-{alpha} Production After Lipopolysaccharide Exposure
J. Immunol.,
September 1, 2003;
171(5):
2625 - 2630.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. H. Han, Y. Chen, M. K. Chang, Y. C. Han, J.-H. Park, S. R. Green, A. Boullier, and O. Quehenberger
LDL activates signaling pathways leading to an increase in cytosolic free calcium and stimulation of CD11b expression in monocytes
J. Lipid Res.,
July 1, 2003;
44(7):
1332 - 1340.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. P. Tiefenbacher, J. Kapitza, V. Dietz, C.-H. Lee, and F. Niroomand
Reduction of myocardial infarct size by fluvastatin
Am J Physiol Heart Circ Physiol,
June 5, 2003;
285(1):
H59 - H64.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. L. Lazar, Y. Bao, Y. Zhang, and S. A. Bernard
Pretreatment with statins enhances myocardial protection during coronary revascularization
J. Thorac. Cardiovasc. Surg.,
May 1, 2003;
125(5):
1037 - 1042.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M Chello, P Mastroroberto, G Patti, A D'Ambrosio, M C. Morichetti, G Di Sciascio, and E Covino
Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass
Heart,
May 1, 2003;
89(5):
538 - 543.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Sasaki, S. Bharwani, P. Jordan, T. Joh, K. Manas, A. Warren, H. Harada, P. Carter, J. W. Elrod, M. Wolcott, et al.
The 3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitor Pravastatin Reduces Disease Activity and Inflammation in Dextran-Sulfate Induced Colitis
J. Pharmacol. Exp. Ther.,
April 1, 2003;
305(1):
78 - 85.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
P.O Bonetti, L.O Lerman, C Napoli, and A Lerman
Statin effects beyond lipid lowering--are they clinically relevant?
Eur. Heart J.,
February 1, 2003;
24(3):
225 - 248.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Majlesi, P. Samorapoompichit, A. W. Hauswirth, G.-H. Schernthaner, M. Ghannadan, M. Baghestanian, A. Rezaie-Majd, R. Valenta, W. R. Sperr, H.-J. Buhring, et al.
Cerivastatin and atorvastatin inhibit IL-3-dependent differentiation and IgE-mediated histamine release in human basophils and downmodulate expression of the basophil-activation antigen CD203c/E-NPP3
J. Leukoc. Biol.,
January 1, 2003;
73(1):
107 - 117.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Dichtl, J. Dulak, M. Frick, H. F. Alber, S. P. Schwarzacher, M. P.S. Ares, J. Nilsson, O. Pachinger, and F. Weidinger
HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle Cells
Arterioscler Thromb Vasc Biol,
January 1, 2003;
23(1):
58 - 63.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Stamatakis, E. Cernuda-Morollon, O. Hernandez-Perera, and D. Perez-Sala
Isoprenylation of RhoB Is Necessary for Its Degradation. A NOVEL DETERMINANT IN THE COMPLEX REGULATION OF RhoB EXPRESSION BY THE MEVALONATE PATHWAY
J. Biol. Chem.,
December 13, 2002;
277(51):
49389 - 49396.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Di Napoli, A.A. Taccardi, M. Oliver, and R. De Caterina
Statins and stroke: evidence for cholesterol-independent effects
Eur. Heart J.,
December 2, 2002;
23(24):
1908 - 1921.
[PDF]
|
|
|
|
|
|
|
M. F. Bellamy, P. A. Pellikka, K. W. Klarich, A. J. Tajik, and M. Enriquez-Sarano
Association of cholesterol levels, hydroxymethylglutaryl coenzyme-a reductase inhibitor treatment, and progression of aortic stenosis in the community
J. Am. Coll. Cardiol.,
November 20, 2002;
40(10):
1723 - 1730.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Stefanadis, K. Toutouzas, M. Vavuranakis, E. Tsiamis, D. Tousoulis, D.B. Panagiotakos, S. Vaina, C. Pitsavos, and P. Toutouzas
Statin treatment is associated with reduced thermal heterogeneity in human atherosclerotic plaques
Eur. Heart J.,
November 1, 2002;
23(21):
1664 - 1669.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Palinski and C. Napoli
Unraveling Pleiotropic Effects of Statins on Plaque Rupture
Arterioscler Thromb Vasc Biol,
November 1, 2002;
22(11):
1745 - 1750.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Pruefer, J. Makowski, M. Schnell, U. Buerke, M. Dahm, H. Oelert, U. Sibelius, U. Grandel, F. Grimminger, W. Seeger, et al.
Simvastatin Inhibits Inflammatory Properties of Staphylococcus aureus{alpha}-Toxin
Circulation,
October 15, 2002;
106(16):
2104 - 2110.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Li, H. Chen, F. Romeo, T. Sawamura, T. Saldeen, and J. L. Mehta
Statins Modulate Oxidized Low-Density Lipoprotein-Mediated Adhesion Molecule Expression in Human Coronary Artery Endothelial Cells: Role of LOX-1
J. Pharmacol. Exp. Ther.,
August 1, 2002;
302(2):
601 - 605.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.J. Sampson, I.R. Davies, J.C. Brown, K. Ivory, and D.A. Hughes
Monocyte and Neutrophil Adhesion Molecule Expression During Acute Hyperglycemia and After Antioxidant Treatment in Type 2 Diabetes and Control Patients
Arterioscler Thromb Vasc Biol,
July 1, 2002;
22(7):
1187 - 1193.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. K. Newby, A. Kristinsson, M. V. Bhapkar, P. E. Aylward, A. P. Dimas, W. W. Klein, D. K. McGuire, D. J. Moliterno, F. W. A. Verheugt, W. D. Weaver, et al.
Early Statin Initiation and Outcomes in Patients With Acute Coronary Syndromes
JAMA,
June 19, 2002;
287(23):
3087 - 3095.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Porreca, C. Di Febbo, G. Baccante, M. Di Nisio, and F. Cuccurullo
Increased transforming growth factor-beta1 circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibition with pravastatin
J. Am. Coll. Cardiol.,
June 5, 2002;
39(11):
1752 - 1757.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Palinski and S. Tsimikas
Immunomodulatory Effects of Statins: Mechanisms and Potential Impact on Arteriosclerosis
J. Am. Soc. Nephrol.,
June 1, 2002;
13(6):
1673 - 1681.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. I. McFarlane, R. Muniyappa, R. Francisco, and J. R. Sowers
Pleiotropic Effects of Statins: Lipid Reduction and Beyond
J. Clin. Endocrinol. Metab.,
April 1, 2002;
87(4):
1451 - 1458.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Baetta, M. Camera, C. Comparato, C. Altana, M. D. Ezekowitz, and E. Tremoli
Fluvastatin Reduces Tissue Factor Expression and Macrophage Accumulation in Carotid Lesions of Cholesterol-Fed Rabbits in the Absence of Lipid Lowering
Arterioscler Thromb Vasc Biol,
April 1, 2002;
22(4):
692 - 698.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. R. Kwak and F. Mach
Statins Inhibit Leukocyte Recruitment: New Evidence for Their Anti-Inflammatory Properties
Arterioscler Thromb Vasc Biol,
August 1, 2001;
21(8):
1256 - 1258.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Dechend, A. Fiebeler, J.-K. Park, D. N. Muller, J. Theuer, E. Mervaala, M. Bieringer, D. Gulba, R. Dietz, F. C. Luft, et al.
Amelioration of Angiotensin II-Induced Cardiac Injury by a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor
Circulation,
July 31, 2001;
104(5):
576 - 581.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Yoshida, T. Sawada, H. Ishii, R. E. Gerszten, A. Rosenzweig, M. A. Gimbrone Jr, Y. Yasukochi, and F. Numano
HMG-CoA Reductase Inhibitor Modulates Monocyte-Endothelial Cell Interaction Under Physiological Flow Conditions In Vitro : Involvement of Rho GTPase-Dependent Mechanism
Arterioscler Thromb Vasc Biol,
July 1, 2001;
21(7):
1165 - 1171.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Palinsk
New Evidence for Beneficial Effects of Statins Unrelated to Lipid Lowering
Arterioscler Thromb Vasc Biol,
January 1, 2001;
21(1):
3 - 5.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. P. Sparrow, C. A. Burton, M. Hernandez, S. Mundt, H. Hassing, S. Patel, R. Rosa, A. Hermanowski-Vosatka, P.-R. Wang, D. Zhang, et al.
Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering
Arterioscler Thromb Vasc Biol,
January 1, 2001;
21(1):
115 - 121.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G. Wagner and R. A. Roth
Neutrophil Migration Mechanisms, with an Emphasis on the Pulmonary Vasculature
Pharmacol. Rev.,
September 1, 2000;
52(3):
349 - 374.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Sadeghi, M. Collinge, R. Pardi, and J. R. Bender
Simvastatin Modulates Cytokine-Mediated Endothelial Cell Adhesion Molecule Induction: Involvement of an Inhibitory G Protein
J. Immunol.,
September 1, 2000;
165(5):
2712 - 2718.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. K. Koh
Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability
Cardiovasc Res,
September 1, 2000;
47(4):
648 - 657.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Ferro, S. Parrotto, S. Basili, C. Alessandri, and F. Violi
Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia
J. Am. Coll. Cardiol.,
August 1, 2000;
36(2):
427 - 431.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. B. Strawn, M. C. Chappell, R. H. Dean, S. Kivlighn, and C. M. Ferrario
Inhibition of Early Atherogenesis by Losartan in Monkeys With Diet-Induced Hypercholesterolemia
Circulation,
April 4, 2000;
101(13):
1586 - 1593.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. B Strawn, R. H Dean, and C. M Ferrario
Novel mechanisms linking angiotensin II and early atherogenesis
Journal of Renin-Angiotensin-Aldosterone System,
March 1, 2000;
1(1):
11 - 17.
[PDF]
|
|
|
|
|
|
|
D. C. Hess, A. M. Demchuk, L. M. Brass, and F. M. Yatsu
HMG-CoA reductase inhibitors (statins): A promising approach to stroke prevention
Neurology,
February 22, 2000;
54(4):
790 - 796.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Vaughan, A. M. Gotto Jr., and C. T. Basson
The evolving role of statins in the management of atherosclerosis
J. Am. Coll. Cardiol.,
January 1, 2000;
35(1):
1 - 10.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. H. Wagner, T. Kohler, U. Ruckschloss, I. Just, and M. Hecker
Improvement of Nitric Oxide-Dependent Vasodilatation by HMG-CoA Reductase Inhibitors Through Attenuation of Endothelial Superoxide Anion Formation
Arterioscler Thromb Vasc Biol,
January 1, 2000;
20(1):
61 - 69.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Pruefer, R. Scalia, and A. M. Lefer
Simvastatin Inhibits Leukocyte-Endothelial Cell Interactions and Protects Against Inflammatory Processes in Normocholesterolemic Rats
Arterioscler Thromb Vasc Biol,
December 1, 1999;
19(12):
2894 - 2900.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Liu, P. Moesner, N. L. Kovach, R. Bailey, A. D. Hamilton, S. M. Sebti, and J. M. Harlan
Integrin-dependent Leukocyte Adhesion Involves Geranylgeranylated Protein(s)
J. Biol. Chem.,
November 19, 1999;
274(47):
33334 - 33340.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Vaughan and N. Delanty
Neuroprotective Properties of Statins in Cerebral Ischemia and Stroke
Stroke,
September 1, 1999;
30(9):
1969 - 1973.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Drexler
Nitric oxide and coronary endothelial dysfunction in humans
Cardiovasc Res,
August 15, 1999;
43(3):
572 - 579.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Lefer, B. Campbell, Y.-K. Shin, R. Scalia, R. Hayward, and D. J. Lefer
Simvastatin Preserves the Ischemic-Reperfused Myocardium in Normocholesterolemic Rat Hearts
Circulation,
July 13, 1999;
100(2):
178 - 184.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. H. Han, K. O. Han, S. R. Green, and O. Quehenberger
Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia: differential effects of plasma lipoproteins on monocyte function
J. Lipid Res.,
June 1, 1999;
40(6):
1053 - 1063.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
N. Hrboticky, G. Draude, G. Hapfelmeier, R. Lorenz, and P. C. Weber
Lovastatin Decreases the Receptor-Mediated Degradation of Acetylated and Oxidized LDLs in Human Blood Monocytes During the Early Stage of Differentiation Into Macrophages
Arterioscler Thromb Vasc Biol,
May 1, 1999;
19(5):
1267 - 1275.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Szczeklik, J. Musial, A. Undas, P. Gajewski, P. Gora, J. Swadzba, and M. Jankowski
Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia
J. Am. Coll. Cardiol.,
April 1, 1999;
33(5):
1286 - 1293.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. H. Han, R. K. Tangirala, S. R. Green, and O. Quehenberger
Chemokine Receptor CCR2 Expression and Monocyte Chemoattractant Protein-1–Mediated Chemotaxis in Human Monocytes : A Regulatory Role for Plasma LDL
Arterioscler Thromb Vasc Biol,
December 1, 1998;
18(12):
1983 - 1991.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. S. Rosenson and C. C. Tangney
Antiatherothrombotic Properties of Statins: Implications for Cardiovascular Event Reduction
JAMA,
May 27, 1998;
279(20):
1643 - 1650.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Baetta, M. Camera, C. Comparato, C. Altana, M. D. Ezekowitz, and E. Tremoli
Fluvastatin Reduces Tissue Factor Expression and Macrophage Accumulation in Carotid Lesions of Cholesterol-Fed Rabbits in the Absence of Lipid Lowering
Arterioscler Thromb Vasc Biol,
April 1, 2002;
22(4):
692 - 698.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. K. Koh, W. H. Schenke, M. A. Waclawiw, G. Csako, and R. O. Cannon III
Statin Attenuates Increase in C-Reactive Protein During Estrogen Replacement Therapy in Postmenopausal Women
Circulation,
April 2, 2002;
105(13):
1531 - 1533.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
